Adipocytes express the rate-limiting enzymes required for glycogen metabolism and increase glycogen synthesis in response to insulin. However, the physiological function of adipocytic glycogen in vivo is unclear, due in part to the low absolute levels and the apparent biophysical constraints of adipocyte morphology on glycogen accumulation. To further study the regulation of glycogen metabolism in adipose tissue, transgenic mice were generated that overexpressed the protein phosphatase-1 (PP1) glycogen targeting subunit PTG driven by the aP2 promoter. Exogenous PTG was detected in gonadal, perirenal, and brown fat depots, but not in any other tissue examined.
INTRODUCTION
Circulating energy sources are maintained in a narrow homeostatic range across a wide variety of physiological conditions through the coordinate regulation of energy uptake, consumption, storage and release by the principal metabolic tissues, namely adipose tissue, liver, and skeletal muscle. During times of energy deficit, adipose tissue is a primary site for energy provision via the hydrolysis of stored triglyceride to release free-fatty acid (FFA) for ATP production and glycerol for hepatic gluconeogenesis.
Conversely, following a meal, dietary lipid is stored by adipose tissue, and glucose is disposed of as glycogen by the skeletal muscle and to a lesser extent by the liver.
Glucose can also be utilized postprandially by the liver and adipocytes for de novo lipogenesis and long-term storage as triglyceride. However, adipocytes also store glucose as glycogen, albeit at substantially lower rates than in skeletal muscle and liver, so the physiological role of adipocytic glycogen metabolism remains unclear.
In addition to its role in lipid metabolism, adipose tissue functions as an endocrine organ through the secretion of a number of factors collectively known as adipokines.
One such factor, leptin, was first identified as the single gene defect responsible for the obesity and hyperphagia seen in the ob/ob mouse (73) , and has since been shown to act centrally at the hypothalamus to regulate feeding behavior (11, 62, 63) and peripherally to promote energy consumption (19, 48, 74) . Circulating leptin levels are directly related to adiposity in both rodents and humans (1, 10, 26, 40) , but are also subject to regulation in response to feeding and fasting (32, 66) , contributing to the daily cycle of serum leptin values (61) . Although relatively little glucose is taken up by the fat cell in comparison to skeletal muscle or liver (5, 41) , insulin-stimulated glucose metabolism synergistically regulates leptin secretion (45, 46, 56) , possibly via transcriptional and/or posttranscriptional mechanisms (35, 44) . However, the metabolic fate(s) of glucose within the adipocyte responsible for the regulated synthesis and release of leptin remains unclear.
Since the 1960's, investigators have sought to determine the major pathways of glucose metabolism within the fat cell. Experiments conducted with primary rat adipocytes demonstrated that 80-85% of glucose metabolized by the fat cell is oxidized to CO 2 or converted to the glyceride glycerol or fatty acid components of triglyceride, 5-Page 4 of 44 15% is catabolized to lactate (12, 39) , and approximately 2-3% is stored as glycogen (16, 43) . Interestingly, at a constant insulin concentration, low concentrations of glucose were preferentially metabolized to glycogen (36) , and glucose conversion to glycogen by the adipocyte was more sensitive to insulin than either CO 2 production or triglyceride synthesis (43) . These experiments led to the hypothesis that glucose entering the fat cell is first used to replenish glycogen stores, but this pathway is saturated quickly and glucose is subsequently shunted to triglyceride synthesis and ATP production (21, 43) .
Glycogen metabolism is regulated by two key enzymes: glycogen synthase, which catalyzes the addition of glucose to the glycogen chain, and glycogen phosphorylase, which catalyzes the breakdown of glycogen to release glucose-1-phosphate. Insulin promotes glycogen synthesis through the coordinate dephosphorylation of glycogen synthase and phosphorylase, resulting in enzymatic activation and inactivation, respectively. Although the precise molecular mechanisms by which insulin regulates glycogen-metabolizing enzymes is very complex and remain controversial, the localized activation of PP1 at glycogen particles plays an important role (8) . Five proteins have been described that target protein phosphatase-1 (PP1) to glycogen chains (2, 13, 14, 47, 57, 64, 65) . One such protein, termed Protein Targeting to Glycogen (PTG), was first identified from 3T3-L1 adipocytes (57) and remains the only PP1 glycogen-targeting subunit reported to be expressed in adipocytes. Importantly, overexpression of PTG in a variety of cell types in vitro and in rodent liver in vivo by several groups markedly enhanced cellular glycogen levels (17, 20, 22, 24, 37, 50, 57, 72) .
Adipose tissue has profound effects on whole body energy homeostasis through the regulated storage and mobilization of triglyceride and secretion of adipokines that influence feeding behavior and insulin sensitivity in other tissues.
However, the potential importance of glycogen metabolism in adipocyte function has not received extensive attention. To further investigate the impact of altering adipocytic glycogen stores, we generated a transgenic mouse model overexpressing PTG in adipose tissue.
We found that elevated PTG expression markedly increased glucose flux into the glycogen synthetic pathway, indicating that adipose tissue is capable of storing far higher levels of glycogen. In contrast, there were no detectable changes in triglyceride synthesis or mobilization in transgenic animals, indicating that adipocytic glycogen metabolism can be modulated in vivo independently of changes in lipid metabolism.
MATERIALS AND METHODS
Transgenic Mouse Generation -The PTG DNA sequence (Genbank U89924) was subcloned into a pBluescript II SK+ vector containing a 5.4 kB aP2 promoter (gift of Dr.
R. Graves), which had been used to obtain transgenic protein overexpression in adipose (9) . PTG was PCR-amplified to add an N-terminal FLAG-tag sequence (DYKDDDDK),
and PvuII and SmaI restriction enzyme cut sites on the 5' and 3' ends, respectively. The Potential founders from multiple litters were screened by Southern blotting (Fig. 1B) as previously described (71). Briefly, DNA was isolated from tail clips with a DNeasy kit (Qiagen) and then BamHI digested for resolution on agarose gel and transferred to Gene Screen Plus Hybridization Membrane (Perkin Elmer Life Sciences). Endogenous PTG is flanked by BamHI cut sites such that restriction digestion with BamHI produces a 7-kB fragment, whereas digestion of exogenous PTG yields a 3.7-kB fragment due to novel BamHI cut sites within the aP2 promoter and poly A tail. Bands were visualized with 32 P-dCTP-labeled probe (American Radiolabeled Chemicals) homologous to the first 500 base pairs of the single PTG exon (Fig. 1B) . Multiple founders were identified and two males were selected for propagation of independent lines for characterization. DNA samples from tail clips of subsequent litters were screened by PCR with primers homologous to the FLAG insert (sense TAAGGTTCCTTCACAAAGATC) and poly A tail (antisense GACCTATAAAGACGACGACGACAAA) that amplified a 1-kB fragment, and with primers specific to the endogenous PTG exon (sense GCCATGAGGATTTGCTTG; antisense TCATTTGGGTGCCACCTG) that amplified an 800-bp fragment in all samples (data not shown).
Mouse Treatment/Care -The transgene was maintained on the CD-1 background throughout the study. CD-1 transgenic and wild-type mice from each line were allowed free access to a standard chow diet and water and maintained on a 12/12 h light/dark cycle under specific pathogen-free conditions in the Carlson Barrier Facility at the University of Chicago. All the procedures involving mice were approved by the University of Chicago Institutional Animal Care and Use Committee. After weaning at 3 weeks of age, tail clippings were taken for genotyping by PCR, and mice were weighed weekly. At 2-3 and 6 months of age, male mice were sacrificed by CO 2 narcosis for the studies described throughout. Brain, kidney, liver, skeletal and cardiac muscle, and gonadal, perirenal, and visceral fat were harvested, frozen on dry ice and stored at -80 o C for future study. Blood was collected by cardiac puncture and centrifuged at 2,300 X g, 4 o C for 5 min to obtain serum.
For the high-fat diet study, wild-type and transgenic 2-month-old male mice were fed either the standard chow diet or a high-fat diet (45% of calories from fat; Research Diets) for 4 weeks. Animals were weighed 3 times a week over the course of 4 weeks, and food consumption was calculated over 3-day intervals for each of the 4 weeks. Fed blood glucose was measured weekly by tail bleeds using an Ascensia Elite XL glucometer (Bayer). Glucose tolerance tests were performed at 2 and 4 weeks after fasting by injecting 2 g/kg dextrose intraperitoneally. Glucose levels were measured from tail bleeds at 0, 15, 30, 60, and 120 min. After 4 weeks, animals were sacrificed and tissue and serum were collected as described above. For fasting studies, animals were fasted overnight. Body weight and blood glucose were recorded pre-and post-fast, and animals were sacrificed for collection of serum and metabolic tissue as described above.
RNA and Protein Analysis -For real-time quantitative reverse transcription (RT)-PCR, RNA was isolated from 200 mg of gonadal fat of wild-type and transgenic mice using Trizol, and RT-PCR was performed to produce cDNA with an iScript cDNA synthesis kit (Bio-Rad). Real-time quantitative RT-PCR was performed as previously described (23) with an iCycler and MyiQ software for data analysis (Bio-Rad) and primers for 18S For protein analysis, immunoblotting was performed as previously described (23) .
Briefly, tissues were lysed with a glass Dounce homogenizer in homogenization buffer (50 mM HEPES (pH 7.4), 150 mM NaCl, 1 mM EDTA, 10 mM NaF, 10% glycerol, and protease inhibitors) and then centrifuged at 500 X g, μl of cells were added to 900 μl of PBS, and lipids were extracted with 4 ml Betafluor (National Diagnostics) for determination of lipogenesis rates. 90 μl of the remaining cells from each condition were added to 1 ml of 30% KOH to determine 14 C-glucose incorporation into glycogen (24) .
Glycogen and Lipid Determinations -Tissues were homogenized and glycogen was measured as described previously (24) . Due to the large differences in adipocytic Statistical analysis -The data shown represent the mean + SEM. Data were compared using unpaired, two-tailed Student's t-tests, and analyses were performed with Microsoft Excel XP. A p value of < 0.05 was considered statistically significant. immunoblotting. PTG protein levels were readily detectable in adipocytic lysates from transgenic mice whereas endogenous PTG was undetectable with the commercially available antibodies (Fig. 2B ). Immunoprecipitation of adipocytic lysates using anti-FLAG antibody followed by anti-PTG immunoblotting confirmed that the increase in PTG protein was due to the overexpression of exogenous PTG (Fig. 2B ). Exogenous PTG was also detected in perirenal and brown fat by Western blotting, but in no other tissue including brain, kidney, liver, and skeletal and cardiac muscle, confirming tissue-specific overexpression (data not shown). Similar results were obtained for each independent line regarding PTG mRNA, protein levels and glycogen accumulation (see below) such that one line was selected for more extensive characterization.
RESULTS

aP2-driven Overexpression of PTG in
Phenotypic Analysis of aP2-PTG Transgenic Mice -Initial observations made in 2-, 3-and 6-month-old wild-type and transgenic male animals revealed no striking differences in a number of broad parameters (Table I ). Similar observations were made for females (data not shown). There was no significant difference in body weight for wild-type and transgenic mice at 2-3 and 6 months of age. Gonadal fat pad weight and food consumption were also approximately equal at both time points, as were blood glucose concentrations, serum triglyceride levels, and FFA values (Table I) . No evidence of abnormalities or change in tissue weight was observed during a gross anatomical survey of gonadal, perirenal, and visceral fat, liver, kidney, heart and skeletal muscle performed during dissection. Additionally, no change in liver or skeletal muscle glycogen content was detected when measured directly or by PAS staining (data not shown). Lastly, primary adipocytes isolated from wild-type and transgenic animals were morphologically similar under light microscopy ( Fig. 3A) .
PTG Overexpression Markedly Increases Adipocytic Glycogen Storage -The effects of
PTG overexpression on adipocytic glycogen stores were then examined. Epididymal fat pads were excised from 2-and 6-month-old animals for determination of total glycogen storage. In wild-type mice, glycogen levels in adipose tissue were low, ranging from approximately 0.5-1.5 μg per mg protein (Fig. 3B ). In parallel with the observed increases in PTG mRNA and protein levels, total glycogen storage was significantly increased in both lines of the transgenic mice, reaching levels as high as 200 μg per mg protein, or 100-400 times more glycogen than in wild-type mice (Fig. 3B) . Changes in gonadal fat glycogen storage were equivalent in transgenic female mice (data not shown)
such that future characterization focused on male animals.
The large increases in glycogen storage were surprising given the low glycogen levels normally present in adipose tissue (16, 43) . In addition, glycogen is a spatially inefficient means of storing energy in that it comprises long branching, hydrophobic chains that require hydration by 3-4 g of water/g of glycogen. Further, adipocytes possess a highly restricted intracellular space due to the densely packed lipid droplet.
Thus, we investigated the localization of glycogen particles in the transgenic adipose tissue. Gonadal fat pads from 2-month-old male wild-type and transgenic mice were excised and fixed overnight for embedding and cross-sectioning in paraffin. Sections were analyzed for general cell morphology (data not shown) and by PAS stain for visualization of intracellular glycogen. Two distinct differences in adipose tissue taken from transgenic mice were observed. First, PAS staining of glycogen in gonadal fat confirmed the marked increase in total cellular glycogen levels in transgenic fat pads, where glycogen was detected as a dark pink coloration that appeared at or near the plasma membrane (Fig. 3C) . Second, adipocytes from transgenic mice appeared wrinkled, most likely resulting from the dehydration step of the fixation process, which would strip the water molecules hydrating the glycogen chains, presumably leading to the collapse of the plasma membranes
Glycogen Targeted PP1 Activity is Elevated in Transgenic Mice -Glycogen synthesis and net glycogen storage represent the summation of a number of extracellular signals that regulate glucose uptake and metabolism and glycogen synthase and phosphorylase activities. Previous work demonstrated that bi-directional modulation of PTG expression in 3T3-L1 adipocytes specifically affected PP1 activity directed against enzymes involved in glycogen metabolism (23, 24) . To initially investigate the mechanism by which PTG overexpression led to enhanced glycogen storage in the adipose tissue of transgenic mice, we determined PP1 protein levels, intracellular localization and in vitro activity. Cell lysates were prepared from gonadal fat pads from three transgenic and three wild-type mice, and cellular levels were determined by immunoblotting. As shown in Figure 4A , there was no detectable difference in PP1 protein expression between the two genotypes. In contrast, PP1 activity against 32 P-labeled glycogen phosphorylase was elevated 2-fold in transgenic lysates (Fig. 4A) , paralleling results obtained upon PTG overexpression in 3T3-L1 adipocytes (24) .
To determine whether overexpression of PTG impacted the cellular distribution of PP1, homogenized gonadal fat pads were fractionated by differential centrifugation.
Lysates were centrifuged at 500 X g to obtain a PNS fraction, followed by ultracentrifugation at 100,000 X g for up to 90 min to separate the cytosolic supernatant fraction from the crude glycogen-enriched pellet. Furthermore, exogenous PTG was largely recovered in the glycogen-enriched pellet (Fig.   4B , lower panel, lane 6), although detectable amounts were found in the cytosolic fraction. Potentially, a portion of PTG was not bound to glycogen due to high levels of protein overexpression, or was released upon cellular homogenization. Since other cellular substructures and organelles are present in the high-speed particulate fraction, the pellet fraction was treated with amylase to digest glycogen and centrifuged again at 100,000 X g to identify glycogen-bound proteins released into the supernatant. Under these conditions, all of the PTG and most of the PP1 were released upon amylase treatment (data not shown), confirming that these proteins in the crude pellet were largely associated with glycogen. Unfortunately, we have exhausted the anti-PTG antibody that previously recognized glycogen-bound PTG in 3T3-L1 adipocytes (23) and commercially available antibodies were unable to detect endogenous adipocytic PTG even in the glycogen-containing fraction.
PTG Overexpression Increases Both Active and Total Glycogen Synthase Activities -An
increase in glycogen-targeted PP1 activity could potentially alter cellular glycogen synthase and/or phosphorylase activities. First, glycogen synthase activity in adipocytic lysates from wild-type and transgenic mice was measured in vitro, in the presence and absence of the allosteric activator glucose-6-phosphate (G6P); activity measured in its absence is indicative of active glycogen synthase present within the cell, while activity measured in its presence corresponds to total glycogen synthase activity. In the absence of G6P, glycogen synthase activity was 6 times greater in transgenic than in wild-type mice (Fig. 5A) , suggesting increased dephosphorylation and/or expression of glycogen synthase. In the presence of G6P, total glycogen synthase activity was also significantly increased in transgenic mice (Fig. 5A, p<0 .01), indicating an increase in enzyme protein levels. Immunoblotting of gonadal fat pad lysates confirmed that glycogen synthase levels were indeed elevated in transgenic mice (Fig. 5B) . The apparent increase by immunoblotting was greater than results from in vitro activity assays (Fig. 5A vs . 5B).
However, this apparent discrepancy may be explained by the finding that the anti-glycogen synthase antibody used recognized the dephosphorylated form of the enzyme more strongly (53) . Thus, the increase in immunoreactive protein is reflective of both elevated glycogen synthase protein levels and enhanced dephosphorylation upon PTG overexpression in transgenic adipose tissue. The changes in glycogen synthase expression most likely result from enhanced protein stabilization secondary to increased glycogen levels, as quantitative real-time RT-PCR detected no significant difference in adipocytic glycogen synthase mRNA levels between the two genotypes (data not shown).
There was also an increase in the amount of phospho-glycogen synthase detected in lysates from transgenic adipocytes (Fig 5B) . However, this modest change is most likely reflective of the larger increase in total enzyme levels resulting from PTG overexpression. Further, the activity ratio for glycogen synthase was markedly increased (0.55 vs. 0.18, transgenic vs. wild type, respectively), corresponding to increased protein dephosphorylation.
Next, the cellular distribution of glycogen synthase was determined by differential centrifugation of homogenized gonadal fat from wild-type and transgenic mice.
Interestingly, overexpression of PTG led to a more pronounced redistribution of glycogen synthase than of PP1 within the cell ( 
Glycogen Phosphorylase Protein Levels and Cellular Distribution are Modulated in
Transgenic Mice -The effects of PTG overexpression on adipocytic glycogen phosphorylase were examined in parallel. In gonadal fat pad lysates from transgenic mice, glycogen phosphorylase protein levels were modestly elevated compared with wild-type, although not as dramatically as glycogen synthase (Fig. 5B) . Additionally, phospho-phosphorylase levels increased in parallel with total enzyme levels. Despite these slight changes in glycogen phosphorylase protein levels and phosphorylation state, no significant difference in enzyme activity assayed in vitro was detected due to the extremely low enzymatic activities in adipocytic lysates from both genotypes (data not shown). Finally, phosphorylase distribution in wild-type and transgenic adipocytes was determined. Overexpression of PTG had a greater effect on phosphorylase localization as compared to PP1 or glycogen synthase, as there was an almost complete redistribution of the phosphorylase from the cytosolic to glycogen-enriched pellet fraction in transgenic adipocyte lysates (Fig. 5C, lower panel) . These data suggested that the dramatic increase in glycogen stores in transgenic adipose tissue resulted in a compensatory change in phosphorylase localization, which may have inhibited further glycogen accumulation.
Overexpression of PTG Enhances Partitioning of Glucose into Glycogen versus Lipid -
The impact of markedly altering adipocytic glycogen storage on glucose flux into glycogen vs. lipid stores was measured. Primary adipocytes were incubated with 14 Cglucose with or without insulin for 60 min and then divided into two equal aliquots, one for determination of glucose incorporation into glycogen and the other for incorporation into lipid. For both wild-type and transgenic animals, the majority of glucose stored under both basal and insulin-stimulated conditions was stored as lipid (97% and 98% wild type, 84% and 73% transgenic; Fig. 6A ). These results are in stark contrast to glucose partitioning experiments in 3T3-L1 adipocytes, in which >85% of the glucose was stored as glycogen and <15% was stored as lipid (24) . Overexpression of PTG significantly increased the amount of 14 C-glucose recovered as glycogen in the absence and presence of insulin compared with wild-type controls ( Fig. 6A; p<0 .01). Basal levels of glycogen synthesis were approximately 4 times greater in transgenic mice, and insulinstimulated rates elevated 16-fold. Interestingly, increasing glucose partitioning to glycogen appeared to reduce the amount of glucose being stored as lipid, although the difference was not significant compared with wild-type animals ( Fig. 6A ; p=0.23 basal, p=0.32 insulin). Furthermore, total glucose storage (calculated as the sum of glucose incorporated into glycogen and triglyceride) under these conditions was also unchanged.
Glycogen synthesis and glucose conversion to triglyceride are both dependent upon glucose transport into the adipocyte via the insulin responsive glucose transporter, Glut4. Immunoblot analyses of gonadal fat pad lysates revealed no change in insulin receptor (IRβ), Glut4 or Akt protein levels (Fig. 6B) . Furthermore, insulin treatment of primary adipocytes from wild-type and transgenic mice demonstrated no striking difference in basal or insulin stimulated phospho-Akt (Fig. 6B) .
Adipocytic Function is Maintained in Transgenic Animals During Fasting and High-fat
Feeding -Adipocytes store and release energy through the hormonal regulation of lipolysis and lipogenesis. To determine the effects of glycogen accumulation upon PTG overexpression on lipolysis and lipogenesis in vivo, two independent studies were conducted. First, 2-month-old animals were fasted overnight or given free access to food.
Both wild-type and transgenic fasted animals experienced an approximate 10% reduction in body weight, or a loss of 3.9 g and 4.0 g, respectively (Fig. 7A ). Fed and fasted blood glucose, FFA, and insulin levels did not differ significantly between groups (Fig. 7B, 7C ),
indicating that glycogen hyper-accumulation did not alter the adipocytic response to hormonal stimuli and mobilization of energy stores during a fast. Glycogen levels in the gonadal fat of transgenic animals dropped upon overnight fasting (Fig. 7D) , with the change approaching statistical significance, indicating that the adipocytic glycogen stores could be mobilized. In contrast, adenoviral-mediated overexpression of PTG in rat livers in vivo or cultured primary hepatocytes prevented glycogen mobilization in response to fasting or forskolin treatment (20, 50 ). This apparent disparity may reflect differences in cell type and/or potential compensatory changes in the transgenic adipocytes upon chronic PTG overexpression vs. acute up-regulation in hepatocytes.
In the second series of studies, 2-month-old wild-type and transgenic mice were randomly chosen and raised on a high-fat or control chow diet for 4 weeks. Both wildtype and transgenic mice on the high-fat diet gained approximately 25% of their initial body weight (Fig. 8A) . Food consumption did not differ between wild-type and transgenic mice on either diet (Fig. 8B ) and changes in blood glucose, FFA, and insulin were also similar (data not shown). Further, glucose tolerance tests performed at the completion of the high-fat feeding demonstrated that both transgenic and wild-type animals developed glucose intolerance to a similar degree (Fig. 8C) . Cumulatively, the in vitro and in vivo data indicated that the elevation of adipocytic glycogen stores in transgenic animals did not affect acute lipogenic rates, lipid accumulation during high-fat feeding or mobilization of triglyceride by a prolonged fast, suggesting potential compartmentalization of energy storage as glycogen and lipid in adipose tissue.
Increased Circulating Leptin Levels in Transgenic Mice -Several lines of evidence
suggest that postprandial changes in circulating insulin induce leptin synthesis and secretion (3, 7, 35) . Furthermore, insulin-stimulated glucose metabolism synergistically increases leptin expression (45, 46, 70) . To determine whether altering the partitioning of glucose between energy storage sites within the adipocyte impacted adipokine expression, gonadal fat pad lysates were analyzed by immunoblotting with antiadiponectin and anti-leptin antibodies on the same membrane. The expression of the adiponectin was similar between the two mouse lines (Fig. 9A) . In contrast, leptin protein content was increased 2-to 3-fold in gonadal fat pad lysates from transgenic mice (Fig. 9A ). To explore these changes further, serum leptin levels were measured by radioimmunoassay. In wild-type animals, leptin levels were 6 ng/ml in agreement with previously published reports ranging from 3-6 ng/ml (33, 51, 52, 58) . Interestingly, a significant increase in circulating leptin levels in 2-month-old male transgenic mice was observed ( Fig. 9B ; p<0.01), in agreement with the immunoblotting results (Fig. 9A ).
These results indicate that enhancement of adipocytic glucose flux into glycogen exerted specific effects on the leptin expression profile, although the molecular mechanism underlying this change is unknown. Despite a doubling in circulating leptin levels in the transgenic animals, there was no detectable change in either food consumption or weight gain (Figs. 8A and 8B), indicating the leptin elevation in the transgenic animals was not profound enough to affect feeding behavior or energy utilization. Additionally, high-fat feeding resulted in a substantial and comparable increase in circulating leptin in both genotypes (Fig. 9C) , indicating that the differences in basal leptin secretion were not preserved upon expansion of adipose mass.
DISCUSSION
While glycogen storage is an important energy reserve for skeletal muscle contraction and increased hepatic glucose output, its function in adipose tissue has not been widely addressed. In rodents, skeletal muscle and liver are the two primary sites of glycogen storage, where approximately 3 μg and 40 μg of glycogen are stored per mg protein, respectively (30, 31, 38, 42, 49, 67, 68) . In contrast, adipocytic glycogen storage in wild-type mice ranged from 0.5-1.5 μg/mg protein in this study. Since the total protein content of adipose tissue is also far less than skeletal muscle or liver, adipocytic glycogen represents a very small portion of whole body glycogen stores. Glycogen is composed of long branching chains of glucose monomers, which are a spatially inefficient means of storing energy especially compared with the densely packed lipid droplet. Since the intracellular space of an adipocyte is highly restricted due to the presence of the large lipid droplet, biophysical restrictions were thought to be a major constraint on adipocytic glycogen accumulation. However, why the fat cell would retain the ability to synthesize glycogen is currently unknown, as was whether an adipocyte could support higher levels of glycogen storage.
In this study, the PP1 glycogen-targeting subunit PTG was overexpressed using Furthermore, partitioning experiments with radiolabeled glucose showed that acute glucose flux into triglyceride, as well as total glucose storage were not impacted by increased flux of glucose into glycogen, potentially suggesting distinct pathways of glucose metabolism into lipid and glycogen.
In order to address the mechanism by which PTG overexpression led to glycogen accumulation, analysis of protein levels, localization, and activity states of the relevant glycogen regulatory enzymes was conducted. PTG overexpression did not affect PP1 expression but caused a moderate increase in PP1 levels bound to glycogen, which in turn correlated with an increase in PP1 activity directed against glycogen phosphorylase in vitro. Additionally, basal and insulin-stimulated glycogen synthase activity ratios were persistently elevated in transgenic adipose tissue, reflective of increased PP1-mediated dephosphorylation of glycogen synthase. Chronically elevated glycogen stores led to a secondary increase in glycogen synthase levels, presumably through increased protein stabilization as mRNA levels were unchanged. In contrast, expression of glycogen phosphorylase was much more modestly altered in the transgenic adipose tissue. PTG overexpression also increased the percentage of cellular glycogen synthase and phosphorylase recovered in the glycogen-enriched pellet fractions, most likely again a secondary effect of the enhanced glycogen stores. Transient overexpression of PTG in 3T3-L1 adipocytes also increased glycogen synthase dephosphorylation and activity, but without any change in total enzyme levels (24). The differences may be due to the 2-3 day overexpression in cells vs. the 2-month overexpression in the animals. Additionally, knockdown of endogenous PTG in 3T3-L1 adipocytes with shRNA revealed that glycogen phosphorylase rather than glycogen synthase is the principal cellular substrate of the PTG:PP1 complex (23) . Thus, the alterations in glycogen synthase dephosphorylation in the transgenic animals may not be fully reflective of endogenous PTG action in adipose tissue in vivo.
Overexpression of PTG resulting in elevated adipocytic glycogen storage occurred in conjunction with a 2-fold increase in circulating leptin. The effect appeared specific, as leptin protein levels in gonadal fat were also increased and adiponectin did not change. Long-term circulating leptin levels have been shown to be directly proportional to adiposity in both humans and rodents (18, 40), while the acute mechanisms responsible for the regulated synthesis and secretion during fasting and refeeding are more complex. Several lines of study have demonstrated that insulin regulates leptin via post-transcriptional mechanisms, including increased synthesis and secretion, as well as by modulating tissue storage and turnover (3, 7, 35, 59) . Work directed at determining the nutrient or signal responsible for the regulation of leptin in response to feeding has implicated the insulin-stimulated metabolism of glucose, as opposed to a direct effect of insulin (6, 15, 45, 46) . Since fat pad masses and body weight were unchanged in transgenic mice, the observed differences in leptin levels were more likely due to changes in glucose flux into the adipocyte than to alterations in adiposity. It is interesting that gonadal fat pad leptin content was elevated in transgenic mice, suggesting increased bio-synthesis, but testing this supposition will require future study.
Despite the observed increase in circulating leptin, no difference in feeding behavior or body weight in the transgenic mice was found. In previous work, daily injections of recombinant leptin for 28 days produced no significant changes in body weight, adiposity, blood glucose or insulin levels in wild-type mice, even at the highest dosage (55) . Only when leptin was administered by constant infusion for 6 days, or as twice daily, high dosage injections was a modest, but significant weight loss observed in wild-type mice (25, 55) . In studies where transgenic overexpression of the ob gene resulted in a lean phenotype, circulating leptin levels were as high as 30, 60 and 100 ng/ml (33, 51, 52) , suggesting that the increases observed here (11.4 + 1.2 ng/ml) were too modest to have a profound effect on feeding behavior.
Although the results presented demonstrate that adipose tissue can sustain far higher levels of glycogen that normally seen in vivo, the physiological role of endogenous glycogen in adipocyte function remains uncertain. During fasting, it has been estimated that approximately 30-40% of the FFA released from triglyceride is retained and recycled back to triglyceride in adipose tissue from rodents and humans (27, 69) . This reesterification is dependent upon a supply of glycerol-3-phosphate, either from glucose via glycolysis or from pyruvate via an often overlooked pathway, termed glyceroneogenesis (reviewed in (60) . The onset of glyceroneogenesis in adipose tissue seems to occur later during fasting as a break on FFA release and hence the onset of ketogenesis by the liver.
Potentially, the earlier production of glycerol-3-phosphate for re-esterification of FFA during fasting could be derived from intracellular glucose or glucose released from glycogen. Thus, increasing adipocytic glycogen storage might be expected to increase In summary, overexpression of PTG in adipose tissues resulted in a dramatic increase in glycogen stores that persisted for up to 1 year. It is important to note that the transgenic lines in this study were generated by overexpression of an endogenous adipocytic protein. Thus, these results suggest that PTG expression may be regulated in adipocytes to ensure the relatively low glycogen levels observed in wild-type adipose tissue. These data further demonstrate that adipocytes are physically capable of storing far greater levels of glycogen than normally occurs in vivo, and surprisingly that adipocytes are able to function normally despite this significant metabolic change.
Therefore, it appears that the required glycogen stores in adipose tissue are low and that further accumulation did not significantly impact adipose tissue development or function.
To conclusively determine the physiological role of adipocytic glycogen storage, future studies that employ gene-silencing technologies to disrupt adipocytic glycogen synthesis would be required. Table Legends   Table I . Characterization of wild-type and transgenic male mice. At 2-3 and 6 months, mice were weighed and then sacrificed for collection and weighing of gonadal fat, and blood was obtained by cardiac puncture for blood glucose determination. Serum was isolated from the remaining blood and used to determine triglyceride and FFA values. Food consumption was monitored every three days over a 4-week period. Data shown are the mean + SEM for 17-19 mice at 2-3 months and 11-15 mice at 6 months per genotype. Both endogenous (7 kb product) and exogenous (3.7 kb product) PTG exons are detectable with this probe such that one band was detected for wild-type mice (Wt) and two bands were observed for transgenic mice (Tg). P-phosphate levels in the supernatant were determined by scintillation counting. Activity measurements were made in triplicate for 4 wild-type and 8 transgenic mice, and data shown are the mean + SEM. PP1 protein levels were determined by anti-PP1 immunoblotting of gonadal fat pad lysates. 100 μg of cellular protein were analyzed. B, gonadal fat pad lysates from wild-type (Wt) and transgenic (Tg) animals were subjected to differential centrifugation to obtain a post-nuclear spin supernatant (PNS), cytosolic, and glycogen-enriched pellet fraction (GEP). The pellet fraction was then resuspended in homogenization buffer, using half the volume of the cytosolic supernatant fraction. Equal volumes of each fraction were then analyzed by anti-PP1 and anti-PTG immunoblotting. Data shown are representative of observations made in three mice per genotype. ** p<0.01. Fig. 5 . PTG overexpression alters the subcellular distribution and activity of glycogen metabolizing enzymes. A, glycogen synthase (GS) activity in gonadal fat pad lysates was measured in vitro. Activity was determined in the absence (active) and presence (total) of 10 mM G6P. Each condition was performed in triplicate for 3 mice per genotype, and data shown are the mean + SEM. B, enzyme levels and phosphorylation state were determined by immunoblotting with anti-GS, anti-phospho GS, anti-phosphorylase (GP), and anti-phospho GP antibodies using gonadal fat pad lysates. 100 μg protein were analyzed for each sample.
Figure Legends
C, GS and GP distribution were determined by immunoblotting with gonadal fat pad lysates following the same centrifugation steps described in Figure 4B . Immunoblotting data shown are representative of three independent determinations. ** p<0.01. Fig. 6 . Glycogen synthesis is increased in adipose tissue of transgenic mice. A, partitioning of glucose into glycogen and triglyceride was determined by incubating isolated primary adipocytes from wild-type and transgenic mice with 14 C-glucose +/-10 nM insulin for 60 min. Each aliquot of cells was then split in half for determination of glucose incorporation into glycogen and lipids in parallel. Each condition was investigated in triplicate, and data shown are the mean + SEM. Data shown are the average of four independent experiments. B, lysates were prepared from three animals of each genotype and protein levels were determined by immunoblotting with anti-IRβ and anti-Glut4 antibodies. 100 μg protein were analyzed. For signaling studies, primary adipocytes from two animals for each genotype were incubated +/-10 nM insulin for 10 min at 37 o C. Immunoblots were probed with anti-phospho-Akt antibody, stripped and then reprobed with anti-Akt antibody. ** p<0.01. Fig. 7 . Fasting of wild-type and transgenic mice results in similar weight loss and changes in sera parameters. A, Wild-type and transgenic male mice were fasted overnight, and weighed pre-and post-treatment. B, Blood glucose was measured preand post-fast using a glucometer and blood obtained from a tail bleed. C, Circulating FFA (mM) and insulin (ng/ml) values were measured from sera as described in the materials and methods. D, Gonadal fat pad glycogen content was measured in fasted and ad libitum fed animals for each genotype, reported here as μg glycogen per mg protein.
Values represent the mean + SEM for 9 mice for each genotype. Fig. 8 . High-fat feeding induces comparable weight gain and glucose intolerance in wildtype and transgenic mice. A, wild-type (Wt) and transgenic (Tg) mice were fed either a chow or high-fat diet for 4 weeks, and changes in body weight were recorded every 3 days, reported here as weekly changes. Left panel, wild-type chow vs. wild-type highfat; right panel, transgenic chow vs. transgenic high-fat. B, mice were maintained 3-4 animals per cage and food was weighed every 3 days over 4 weeks, reported here as grams consumed per mouse per day. C, glucose tolerance tests were performed after 4 weeks of the dietary intervention as described in the materials and methods. Blood glucose values were significantly greater (p<0.05) at all times points following injection for high-fat vs. chow fed animals for both genotypes. Values represent the mean + SEM for 7-11 mice per genotype per condition. ** p<0.01; ***p<0.001. Fig. 9 . Overexpression of PTG increases circulating leptin and protein levels in adipose tissue. A, Samples were resolved by PAGE and transferred to nitrocellulose for antileptin and anti-adiponectin immunoblotting on the same membrane. 100 μg protein were analyzed. B, 2-month-old wild-type and transgenic mice were sacrificed, and blood was collected by cardiac puncture. Serum was isolated by centrifugation, and leptin was measured by radioimmunoassay. Values are the mean + SEM of 6-7 mice for each genotype. C, Sera collected during the high-fat diet study was analyzed for leptin content by radioimmunoassay. Values represent the mean + SEM for 10-11 mice for each condition. ** p<0.01. 
